Extracorporeal liver support.
作者信息
Stange Jan
机构信息
Department of Internal Medicine, University of Rostock, Rostock, Germany.
出版信息
Organogenesis. 2011 Jan-Mar;7(1):64-73. doi: 10.4161/org.7.1.14069. Epub 2011 Jan 1.
Abstract
摘要
相似文献
1
Extracorporeal liver support.
Organogenesis. 2011 Jan-Mar;7(1):64-73. doi: 10.4161/org.7.1.14069. Epub 2011 Jan 1.
2
MARS: a new treatment for hepatorenal failure. Molecular adsorbent and recirculating system.
Gastroenterology. 2000 Dec;119(6):1799-800. doi: 10.1016/s0016-5085(00)70033-3.
3
Artificial liver support at present and in the future.
J Artif Organs. 2006;9(1):17-28. doi: 10.1007/s10047-005-0320-1.
4
[Model selection and curative effect judgment criteria for artificial liver in the treatment of liver failure].
Zhonghua Gan Zang Bing Za Zhi. 2022 Feb 20;30(2):127-130. doi: 10.3760/cma.j.cn501113-20220108-00008.
5
Clearing of toxic substances: are there differences between the available liver support devices?
Liver Int. 2011 Sep;31 Suppl 3:5-8. doi: 10.1111/j.1478-3231.2011.02588.x.
6
Artificial hepatic support. Where are we now?
Blood Purif. 2001;19(1):1-3. doi: 10.1159/000014469.
7
[Liver failure].
Nihon Rinsho. 2004 May;62 Suppl 5:545-9.
8
Successful MARS treatment in severe cholestatic patients with acute on chronic liver failure.
Artif Organs. 2003 Jun;27(6):565-9. doi: 10.1046/j.1525-1594.2003.07138.x.
9
[Coping with shortage of plasma and albumin: a strategy for artificial liver].
Zhonghua Gan Zang Bing Za Zhi. 2009 May;17(5):330-1.
10
[Apheresis treatment for fulminant hepatitis].
Nihon Rinsho. 2004 May;62 Suppl 5:462-6.
引用本文的文献
1
Extracorporeal organ support and the kidney.
Front Nephrol. 2022 Aug 5;2:924363. doi: 10.3389/fneph.2022.924363. eCollection 2022.
2
Extracorporeal liver support techniques: a comparison.
J Artif Organs. 2024 Sep;27(3):261-268. doi: 10.1007/s10047-023-01409-9. Epub 2023 Jun 19.
3
Aggregate Removal Nanofiltration of Human Serum Albumin Solution Using Nanocellulose-Based Filter Paper.
Biomedicines. 2020 Jul 13;8(7):209. doi: 10.3390/biomedicines8070209.
4
Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007-2015.
BMC Gastroenterol. 2019 Sep 3;19(1):160. doi: 10.1186/s12876-019-1077-y.
5
Effects of therapeutic plasma exchange on liver function test and coagulation parameters in acute liver failure patients.
Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):125-128. doi: 10.1016/j.htct.2019.05.003. Epub 2019 Jul 23.
6
Novel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment.
J Intensive Care Soc. 2019 May;20(2):174-181. doi: 10.1177/1751143718772789. Epub 2018 May 28.
7
CAAP48, a New Sepsis Biomarker, Induces Hepatic Dysfunction in an Liver-on-Chip Model.
Front Immunol. 2019 Feb 25;10:273. doi: 10.3389/fimmu.2019.00273. eCollection 2019.
8
Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification.
PLoS One. 2018 Jan 24;13(1):e0191741. doi: 10.1371/journal.pone.0191741. eCollection 2018.
9
Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support.
Sci Rep. 2017 Jan 12;7:40323. doi: 10.1038/srep40323.
本文引用的文献
1
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis.
Liver Transpl. 2008 Sep;14(9):1333-9. doi: 10.1002/lt.21504.
2
Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.
Artif Organs. 2008 Jul;32(7):499-508. doi: 10.1111/j.1525-1594.2008.00581.x.
3
The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients.
Transpl Int. 2008 Sep;21(9):857-66. doi: 10.1111/j.1432-2277.2008.00698.x. Epub 2008 May 29.
4
Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study.
World J Gastroenterol. 2008 Apr 7;14(13):2065-71. doi: 10.3748/wjg.14.2065.
5
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.
Hepatology. 2007 Dec;46(6):1853-62. doi: 10.1002/hep.21930.
6
Pediatric ventricular assist devices.
Pediatr Cardiol. 2007 Mar-Apr;28(2):149-55. doi: 10.1007/s00246-006-1453-6. Epub 2007 Jan 29.
7
A novel plasma filtration therapy for hepatic failure: preclinical studies.
Ther Apher Dial. 2006 Apr;10(2):138-44. doi: 10.1111/j.1744-9987.2006.00355.x.
8
Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients.
J Gastrointest Surg. 2005 Nov;9(8):1155-61; discussion 1161-2. doi: 10.1016/j.gassur.2005.07.026.
9
Is alcoholic hepatitis an indication for transplantation? Current management and outcomes.
Liver Transpl. 2005 Nov(11 Suppl 2):S21-4. doi: 10.1002/lt.20601.
10
Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management.
Liver Transpl. 2004 Dec;10(12):1531-8. doi: 10.1002/lt.20323.
Zotero 插件